GBR_Main_Tile

The Generative Biology Revolution - Q&A
July 20, 2022 @ 2:30 PM Eastern Time
Join us for a Q&A webinar event and explore The Generative Biology Revolution, a special edition podcast series produced by The Scientist’s Creative Services team and brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines.

Generative biology is a revolutionary approach to drug discovery and development that leverages machine learning and AI to design novel protein therapeutics. It holds the potential to enhance the speed and efficiency of discovery and increase success rates of bringing life-saving medicines to patients who need them most.

In this webinar event, Marissa Mock from Amgen will answer questions that delve deeper into the entire podcast series.

Visit this page to access the Generative Biology Revolution podcast series!

Q&A Speaker
Mock
Marissa Mock, PhD
Director
Generative Biology
Amgen

Sponsor
Amgen.png

Sign up for the Q&A now

TS_Webinar_Amgen_Series 2_Undruggable_IO#403179

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this Q&A. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these events free of charge for our readers.

The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com

Privacy Policy

© 1986-2022  The Scientist
 
The Scientist Logo_white

The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.